Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial

A K Burnett, R K Hills, D Grimwade, J V Jovanovic, J Craig, M F Mcmullin, J Kell, K Wheatley, J A L Yin, A Hunter, D Milligan, N H Russell

Research output: Contribution to journalArticlepeer-review

59 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science